Molecular pathways that differentiate Hürthle cell adenoma from HCC with wide invasiveness included the PIK3CA-Akt-mTOR and Wnt, providing rationale toward new targets of this type of malignancy [67]. The gene discussed is MTOR; the disease is hepatocellular carcinoma.